# Standardized reporting of perioperative complications after male artificial urinary sphincter implantation

**Authors:** Navid Roessler, Malte W. Vetterlein, Tim H. J. Konrad, Robert J. Schulz, Max C. Wagner, Jakob Klemm, Shahrokh F. Shariat, Roland Dahlem, Margit Fisch, Tim A. Ludwig

PMC · DOI: 10.1007/s00345-026-06246-y · 2026-02-10

## TL;DR

This study evaluates complications and outcomes of artificial urinary sphincter implantation in men, using standardized reporting guidelines to improve transparency and comparability across studies.

## Contribution

The study introduces standardized complication reporting for AUS implantation aligned with EAU guidelines, enhancing systematic evaluation and cross-study comparability.

## Key findings

- 47% of AUS implantations experienced complications, with bleeding being the most common.
- Major complications requiring reintervention occurred in 7.9% of cases.
- Explantation-free survival at 5 years was 73%, with infections and erosion being primary reasons for explantation.

## Abstract

To systematically assess perioperative complications after artificial urinary sphincter (AUS) implantation using the European Association of Urology (EAU) complication reporting guidelines and evaluate long-term device outcomes.

We retrospectively analyzed male patients undergoing AUS implantation between 2015 and 2020. Demographic, clinical, and surgical characteristics were described. Early complications within 6 weeks were captured using a procedure-specific complication catalog and graded according to the Clavien–Dindo Classification (CDC), in line with EAU standardized reporting recommendations. Primary endpoints were overall and major complications (CDC grade ≥ III); secondary endpoint was explantation-free survival.

A total of consecutive 227 AUS implantations (median age 73 years, IQR 67–76) were included. Severe stress urinary incontinence was predominantly post-radical prostatectomy (81%). Cuff types included distal double cuff (58%), bulbar single cuff (26%), and transcorporal cuff (16%). Complications occurred in 47% of cases, most frequently bleeding events (61%), followed by genitourinary (12%) and infectious events (11%). Major complications requiring a reintervention occurred in 7.9% of cases. Median follow-up was 52 months (IQR 32–66), with 5-year explantation-free survival of 73%. Explantation was required in 23% of cases, primarily due to urethral erosion and infection.

AUS implantation is associated with frequent early complications, though most are minor. Applying a predefined, procedure-specific complication catalog according to EAU guidelines ensures systematic, comprehensive, and transparent reporting. This approach highlights clinically relevant events, supports cross-study comparability, and informs individualized patient counseling and perioperative management.

The online version contains supplementary material available at 10.1007/s00345-026-06246-y.

## Linked entities

- **Diseases:** infection (MONDO:0005550)

## Full-text entities

- **Diseases:** stricture disease (MESH:D003251), SUI (MESH:D014550), bleeding (MESH:D006470), bacteriuria (MESH:D001437), diabetes mellitus (MESH:D003920), detrusor overactivity (MESH:D053201), urethral erosion (MESH:D014526), prostate cancer (MESH:D011471), Hematomas (MESH:D006406), Bleeding complications (MESH:D008107), infectious (MESH:D003141), benign prostatic obstruction (MESH:D011472), incontinence (MESH:D014549), coronary artery disease (MESH:D003324), thromboembolic (MESH:D013923), ASA III-IV (MESH:C000719191), AUS (MESH:D009122), Postoperative complications (MESH:D011183), urethral damage (MESH:D014522), infection (MESH:D007239), urethral stricture (MESH:D014525), urinary retention (MESH:D016055), hypertension (MESH:D006973), CDC (MESH:D008310), deaths (MESH:D003643)
- **Chemicals:** gentamicin (MESH:D005839), cefuroxime (MESH:D002444)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12891164/full.md

---
Source: https://tomesphere.com/paper/PMC12891164